Search companies or stocks...
KYMRKymera Therapeutics, Inc.
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing…
Current stock price of Kymera Therapeutics, Inc. (KYMR) stock is $119.05. The stock price is +0.20% higher in the session. The intraday range can be seen from this page. Volume of Kymera Therapeutics, Inc. (KYMR) stock is 576.56K.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Kymera Therapeutics, Inc. (KYMR) can change with earnings, company news, and overall market sentiment. Kymera Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Kymera Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KYMR on this page is -37.20. EPS on this page is -3.20. Compare those figures with peers and growth expectations before deciding if the current Kymera Therapeutics, Inc. price is justified.
Historical performance for Kymera Therapeutics, Inc. (KYMR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KYMR reacted to past earnings and market events.
Buying Kymera Therapeutics, Inc. (KYMR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
